Results 91 to 100 of about 5,470,060 (264)
TrialsBackground Graves’ orbitopathy (GO) is a prevalent manifestation of Graves’ disease (GD), characterized by proptosis, eyelid retraction, soft tissue swelling, diplopia, and potential visual acuity impairment.
Chia-Hung Lin +9 more
doaj +1 more source
The Influence of Juvenile Graves’ Ophthalmopathy on Graves’ Disease Course
Journal of Ophthalmology, 2017 Purpose. To investigate juvenile Graves’ ophthalmopathy (GO) signs and compare Graves’ disease (GD) course in patients with or without GO. Patients and Methods.
Jurate Jankauskiene, Dalia Jarusaitiene
doaj +1 more source
Autoimmunity and Graves’ Disease [PDF]
Clinical Pharmacology & Therapeutics, 2012 Current treatment options for Graves' hyperthyroidism and the related ophthalmopathy (GO) are not uniformly effective and carry with them potentially serious side effects. As a result, efforts have been focused on the development of novel therapies. Progress has been made, particularly in the production of thyroid-stimulating hormone receptor (TSHR ...
openaire +2 more sources
Enclosure – Letter from David Graves
, 1938 Page from Robert Graves diary manuscript. The diary includes 1,546 pages with 117 enclosures: letters, clippings, photographs post cards, notes ...
Graves, Robert, 1895-1985
core
Advanced Healthcare Materials, EarlyView.The role of viscoelasticity in the invasion of heterogeneous glioblastoma stem cells (GSCs) was investigated with GSCs categorized into subgroups based on molecular profile, as Reactive, Invasive, or Constructive using viscoelastic biomimetic hyaluronan‐oxime hydrogels.
Nicole J. Blaine +4 more
wiley +1 more source
Enclosure – Photograph of David Graves
, 1937 Page from Robert Graves diary manuscript. The diary includes 1,546 pages with 117 enclosures: letters, clippings, photographs post cards, notes ...
Graves, Robert, 1895-1985
core
Hemocompatible Glycogen‐Tissue Plasminogen Activator Complexes for Enhanced Blood Clot Dissolution
Advanced Healthcare Materials, EarlyView.Glycogen–heparin‐cRGD nanoparticles enable targeted delivery of tissue plasminogen activator (tPA) to thrombi through activated platelet recognition. The hemocompatible hybrids minimize interactions with blood and immune cells while retaining enzymatic biodegradability.
Nadiia Davydiuk +6 more
wiley +1 more source
Клиническая и экспериментальная тиреоидология, 2013 The aim of the study was to examine the system of tumor necrosis factor α(TNFα), depending on the functional and morphological outcome of Graves’ disease (GD).
doaj +1 more source
Biomass DNA: An Emerging Building Block for Advanced Materials
Advanced Materials, EarlyView.Biomass DNA is rapidly emerging from its traditional role as a genetic blueprint to serve as a versatile abundant, highly programmable polymeric building block. This review highlights the transformation of macroscopic bulk biomass DNA into next generation of functional materials, spanning from dynamic hydrogels, sustainable bioplastics, and high ...
Yuwei Hu, Itamar Willner, Li Niu
wiley +1 more source
Neonatal Graves’ disease from high maternal TRAB antibody levels despite definitive therapy
Journal of Clinical and Translational Endocrinology Case ReportsBackground: Graves’ disease is an autoimmune thyroid disorder that poses significant risks during pregnancy, affecting both the mother and fetus. Case presentation: We present four cases of neonatal Graves' disease arising in the offspring of two women ...
Dalal S. Ali +4 more
doaj +1 more source